Key facts
- This page summarizes Ginger Gregory's Form 4 filing for BIOGEN INC. (BIIB).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 12 Dec 2022, 19:00.
Ginger Gregory - 14 Nov 2022 Form 4 Insider Report for BIOGEN INC. (BIIB)
- Reporting relationship
- EVP, Human Resources
- Issuer ticker
- BIIB
- Reported as of
- 14 Nov 2022
- Net transaction value
- -$1,683,617
- SEC form
- 4
- Accepted by SEC
- 12 Dec 2022, 19:00:05 UTC
- Prior SEC filing
- 23 Feb 2022
- Next SEC filing
- 27 Jan 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Wendell Taylor, attorney in fact for Ginger Gregory
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Ginger Gregory filed Form 4 for BIOGEN INC. (BIIB) on 12 Dec 2022.
Change
- Previous filing in this sequence was filed on 23 Feb 2022.
- Current net transaction value: -$1,683,617.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BIIB
transaction
Common Stock
Sale
- Transaction value
- $1,683,617
- Shares
- -5,610
- Change %
- -50%
- Price
- $300.11
- Shares after
- 5,711
- Date
- 14 Nov 2022
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Footnote F2
Includes 102.4003 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2022.